Subsequently, curcumin and dasatinib downregulated the downstream effectors and NF-κB activity, resulting in the inhibition of cell proliferation, invasion, and colonosphere formation in CRC cells [107]. This evidence concerns the gene NFKB1 and colorectal carcinoma.